Basal and α1-adrenergic-induced activity of minimal rat βMHC promoters in cardiac myocytes requires multiple TEF-1 but not NFAT binding sites

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 5, 2003, Pages 461-471

  McLean, B Gail ^a   Lee, Katherine S ^a   Simpson, Paul C ^b   Farrance, Iain K G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertrophy; MCAT; NFAT; Phenylephrine; TEF 1; Transcription; 1 Adrenergic response

Indexed keywords

CALCINEURIN; MYOSIN HEAVY CHAIN; PHENYLEPHRINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR TEF 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONSENSUS SEQUENCE; DNA TRANSFECTION; GENE ACTIVITY; GENE CONTROL; GENETIC CONSERVATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; MAMMAL; MOUSE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; RAT; SLOW MUSCLE FIBER; SPECIES COMPARISON; TRANSCRIPTION INITIATION SITE;

MAMMALIA;

EID: 0038298908     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00049-X     Document Type: Article

References (67)

1. Simpson P.C., Kariya K., Karns L.R., Long C.S., Karliner J.S. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem. 104:1991;35-43.
2. Simpson P.C., Long C.S., Waspe L.E., Henrich C.J., Ordahl C.P. Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 21:(Suppl V):1989;79-89.
3. McKinsey T.A., Olson E.N. Cardiac hypertrophy: sorting out the circuitry. Curr Opin Genet Dev. 9:1999;267-274.
4. Molkentin J.D., Dorn I.I.I.G. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 63:2001;391-426.
5. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 100:1997;2362-2370.
6. Vikstrom K.L., Bohlmeyer T., Factor S.M., Leinwand L.A. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res. 82:1998;773-778.
7. 1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem. 269:1994;3775-3782.
8. Wright C.E., Bodell P.W., Haddad F., Qin A.X., Baldwin K.M. In vivo regulation of the beta-myosin heavy chain gene in hypertensive rodent heart. Am J Physiol Cell Physiol. 280:2001;C1262-1276.
9. Morimoto T., Hasegawa K., Kaburagi S., Kakita T., Masutani H., Kitsis R.N., et al. GATA-5 is involved in leukemia inhibitory factor-responsive transcription of the beta-myosin heavy chain gene in cardiac myocytes. J Biol Chem. 274:1999;12811-12818.
10. Hasegawa K., Lee S.J., Jobe S.M., Markham B.E., Kitsis R.N. Cis-acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. (see comments) Circulation. 96:1997;3943-3953.
11. Larkin S.B., Farrance I.K., Ordahl C.P. Flanking sequences modulate the cell specificity of M-CAT elements. Mol Cell Biol. 16:1996;3742-3755.
12. Maeda T., Mazzulli J.R., Farrance I.K., Stewart A.F. Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes. J Biol Chem. 277:2002;24346-24352.
13. Larkin S.B., Ordahl C.P. Multiple layers of control in transcriptional regulation by MCAT elements and the TEF-1 protein family. Harvey R.p, Rosenthal N. Heart development. 1999;307-329 Academic Press, London.
14. Chen Z., Friedrich G.A., Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Gene Dev. 8:1994;2293-2301.
15. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
16. Xia Y., McMillin J.B., Lewis A., Moore M., Zhu W.G., Williams R.S., et al. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem. 275:2000;1855-1863.
17. Rothermel B.A., McKinsey T.A., Vega R.B., Nicol R.L., Mammen P., Yang J., et al. Myocyte-enriched calcineurin-interacting protein. MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA. 98:2001;3328-3333.
18. Zou Y., Hiroi Y., Uozumi H., Takimoto E., Toko H., Zhu W., et al. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation. 104:2001;97-101.
19. De Windt L.J., Lim H.W., Bueno O.F., Liang Q., Delling U., Braz J.C., et al. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA. 98:2001;3322-3327.
20. Wilkins B.J., De Windt L.J., Bueno O.F., Braz J.C., Glascock B.J., Kimball T.F., et al. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol. 22:2002;7603-7613.
21. Karns L.R., Kariya K., Simpson P.C. M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem. 270:1995;410-417.
22. Maeda T., Sepulveda J., Chen H., Stewart A. Alpha(1)-adrenergic activation of the cardiac ankyrin repeat protein gene in cardiac myocytes. Gene. 2002;297:1.
23. Aihara Y., Kurabayashi M., Saito Y., Ohyama Y., Tanaka T., Takeda S., et al. Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension. 36:2000;48-53.
24. Long C.S., Henrich C.J., Simpson P.C. A growth factor for cardiac myocytes is produced by cardiac non-myocytes. Cell Regul. 2:1991;1081-1095.
25. Xiao J.H., Davidson I., Matthes H., Garnier J.M., Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell. 65:1991;551-568.
26. Zuzarte P.C., Farrance I.K., Simpson P.C., Wildeman A.G. Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation. Biochim Biophys Acta. 1517:2000;82-90.
27. Hoey T., Sun Y.L., Williamson K., Xu X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity. 2:1995;461-472.
28. Farrance I.K., Ordahl C.P. The role of transcription enhancer factor-1 (TEF-1) related proteins in the formation of M-CAT binding complexes in muscle and non-muscle tissues. J Biol Chem. 271:1996;8266-8274.
29. Flink I.L., Edwards J.G., Bahl J.J., Liew C.C., Sole M., Morkin E. Characterization of a strong positive cis-acting element of the human beta-myosin heavy chain gene in fetal rat heart cells. J Biol Chem. 267:1992;9917-9924.
30. Shimizu N., Prior G., Umeda P.K., Zak R. Cis-acting elements responsible for muscle-specific expression of the myosin heavy chain beta gene. Nucleic Acid Res. 20:1992;1793-1799.
31. Thompson W.R., Nadal-Ginard B., Mahdavi V. A MyoD1-independent muscle-specific enhancer controls the expression of the β-myosin heavy chain gene in skeletal and cardiac muscle cells. J Biol Chem. 266:1991;22678-22688.
32. Kariya K., Farrance I.K., Simpson P.C. Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter. J Biol Chem. 268:1993;26658.
33. Farrance I.K., Mar J.H., Ordahl C.P. M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1. J Biol Chem. 267:1992;17234-17240.
34. Shimizu N., Smith G., Izumo S. Both a ubiquitous factor mTEF-1 and a distinct muscle-specific factor bind to the M-CAT motif of the myosin heavy chain beta gene. Nucleic Acid Res. 21:1993;4103-4110.
35. Blatt C., DePamphilis M.L. Striking homology between mouse and human transcription enhancer factor-1 (TEF-1). Nucleic Acid Res. 21:1993;747-748.
36. Mar J.H., Ordahl C.P. M-CAT binding factor, a novel trans-acting factor governing muscle-specific transcription. Mol Cell Biol. 10:1990;4271-4283.
37. Tsika R.W., McCarthy J., Karasseva N., Ou Y., Tsika G.L. Divergence in species and regulatory role of beta-myosin heavy chain proximal promoter muscle-CAT elements. Am J Physiol Cell Physiol. 283:2002;C1761-1775.
38. Kariya K., Karns L.R., Simpson P.C. Expression of a constitutively-activated mutant of the β-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the β-myosin heavy chain isogene. J Biol Chem. 266:1991;10023-10026.
39. Stewart A.F., Suzow J., Kubota T., Ueyama T., Chen H.H. Transcription factor RTEF-1 mediates alpha1-adrenergic reactivation of the fetal gene program in cardiac myocytes. Circ Res. 83:1998;43-49.
40. Edwards J.G., Bahl J.J., Flink I., Milavetz J., Goldman S., Morkin E. A repressor region in the human beta-myosin heavy chain gene that has a partial position dependency. Biochem Biophys Res Commun. 189:1992;504-510.
41. Ichida M., Finkel T. Ras regulates NFAT3 activity in cardiac myocytes. J Biol Chem. 276:2001;3524-3530.
42. Herzig T.C., Jobe S.M., Aoki H., Molkentin J.D., Cowley Jr A.W., Izumo S., et al. Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci USA. 94:1997;7543-7548.
43. Thuerauf D.J., Arnold N.D., Zechner D., Hanford D.S., DeMartin K.M., McDonough P.M., et al. p38 Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6. J Biol Chem. 273:1998;20636-20643.
44. Sussman M.A., Lim H.W., Gude N., Taigen T., Olson E.N., Robbins J., et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 281:1998;1690-1693.
45. Thuerauf D.J., Glembotski C.C. Differential effects of protein kinase C, Ras, and Raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal M-CAT element. J Biol Chem. 272:1997;7464-7472.
46. Vyas D.R., McCarthy J.J., Tsika G.L., Tsika R.W. Multiprotein complex formation at the beta myosin heavy chain distal muscle CAT element correlates with slow muscle expression but not mechanical overload responsiveness. J Biol Chem. 276:2001;1173-1184.
47. Knotts S., Rindt H., Neumann J., Robbins J. In vivo regulation of the mouse beta myosin heavy chain gene. J Biol Chem. 269:1994;31275-31282.
48. Huey K.A., Roy R.R., Haddad F., Edgerton V.R., Baldwin K.M. Transcriptional regulation of the type I myosin heavy chain promoter in inactive rat soleus. Am J Physiol Cell Physiol. 282:2002;C528-537.
49. Giger J.M., Haddad F., Qin A.X., Baldwin K.M. Functional overload increases beta-MHC promoter activity in rodent fast muscle via the proximal MCAT (beta3) site. Am J Physiol Cell Physiol. 282:2002;C518-527.
50. Giger J.M., Haddad F., Qin A.X., Baldwin K.M. In vivo regulation of the beta-myosin heavy chain gene in soleus muscle of suspended and weight-bearing rats. Am J Physiol Cell Physiol. 278:2000;C1153-1161.
51. Barolo S., Posakony J.W. Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. Gene Dev. 16:2002;1167-1181.
52. Vyas D.R., McCarthy J.J., Tsika R.W. Nuclear protein binding at the beta-myosin heavy chain A/T-rich element is enriched following increased skeletal muscle activity. J Biol Chem. 274:1999;30832-30842.
53. Rindt H., Gulick J., Knotts S., Neumann J., Robbins J. In vivo analysis of the murine beta-myosin heavy chain gene promoter. J Biol Chem. 268:1993;5332-5338.
54. Mar J.H., Antin P.B., Cooper T.A., Ordahl C.P. Analysis of the upstream regions governing expression of the chicken cardiac troponin T gene in embryonic cardiac and skeletal muscle cells. J Cell Biol. 107:1988;573-585.
55. Mar J.H., Ordahl C.P. A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter. Proc Natl Acad Sci USA. 85:1988;6404-6408.
56. Molkentin J.D., Markham B.E. An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo. Mol Cell Biol. 14:1994;5056-5065.
57. Gupta M.P., Gupta M., Zak R. An E-box/M-CAT hybrid motif and cognate binding protein(s) regulate the basal muscle-specific and cAMP-inducible expression of the rat cardiac alpha-myosin heavy chain gene. J Biol Chem. 269:1994;29677-29687.
58. O'Connell T.D., Rokosh D.G., Simpson P.C. Cloning and characterization of the mouse alpha1C/A-adrenergic receptor gene and analysis of an alpha1C promoter in cardiac myocytes: role of an MCAT element that binds transcriptional enhancer factor-1 (TEF-1). Mol Pharmacol. 59:2001;1225-1234.
59. Swartz E.A., Johnson A.D., Owens G.K. Two MCAT elements of the SM alpha-actin promoter function differentially in SM vs. non-SM cells. Am J Physiol. 275:1998;C608-618.
60. Gupta M.P., Amin C.S., Gupta M., Hay N., Zak R. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol. 17:1997;3924-3936.
61. Gupta M., Kogut P., Davis F.J., Belaguli N.S., Schwartz R.J., Gupta M.P. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1. J Biol Chem. 276:2001;10413-10422.
62. Maeda T., Gupta M.P., Stewart A.F. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun. 294:2002;791-797.
63. Vassilev A., Kaneko K.J., Shu H., Zhao Y., DePamphilis M.L. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Gene Dev. 15:2001;1229-1241.
64. Vaudin P., Delanoue R., Davidson I., Silber J., Zider A. TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation. Development. 126:1999;4807-4816.
65. Belandia B., Parker M.G. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem. 275:2000;30801-30805.
66. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowitz M., et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19:2000;6778-6791.
67. Maeda T., Chapman D.L., Stewart A.F. Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J Biol Chem. 277:2002;48889-48898.